Survival and risk factors associated with uterine sarcomas and carcinosarcomas in stage I and II. Visnovsky J, Kudela E, Slavik P, Krkoska M, Buocik P, Szepe P, Danko J. Journal Article 2015; 36(8): 750-757 PubMed PMID: 26921575 Keywords: Adult, Aged, Aged, 80 and over, Antineoplastic Agents:therapeutic use, Body Mass Index, CA-125 Antigen:metabolism, Carcinosarcoma:metabolism, Cohort Studies, Female, Humans, Lymph Node Excision, Lymph Nodes:pathology, Menopause, Middle Aged, Neoplasm Stag. Citation OBJECTIVE: Uterine sarcomas are rare mesodermal malignant tumors with an incidence between 0.5 and 3.3 cases per 100,000 females per year...... Read abstract Full text PDF